---
title: "Australian Meningococcal Surveillance Report 2025: Epidemiology, Genogroups, and Susceptibility"
id: "pubmed-43035020"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43035020"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43035020/"
doi: "10.33321/cdi.2026.50.063"
published_at: "2026-11-16T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Australian Meningococcal Surveillance Report 2025: Epidemiology, Genogroups, and Susceptibility
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43035020
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43035020/)
- **DOI:** [10.33321/cdi.2026.50.063](https://doi.org/10.33321%2Fcdi.2026.50.063)
- **Published At:** 2026-11-16T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The National Notifiable Diseases Surveillance System recorded 118 notifications of invasive meningococcal disease (IMD) in Australia in 2025, a 13% decrease from 2024. - Laboratory confirmation was available for 115 of 118 cases (97%), with 66% (76/115) diagnosed by culture and 34% (39/115) by nucleic acid amplification testing. - Genogroup was determined in 107/115 (93%) laboratory-confirmed cases; **MenB** accounted for 82.2% (88/107) of these infections. - **MenW** and **MenY** each represented 7.5% (8/107) of genogrouped cases; **MenC** was 1.9% (2/107) and **MenA** 0.9% (1/107). - Finetyping data were available for 72/107 (67%) genogrouped cases; among **MenB** isolates, 28 porA types were detected with P1.7-2,4 (21%; 12/58) and P1.7,16-26 (14%; 8/58) most common. - Six of eight **MenW** isolates were finetyped as porA P1.5,2, MLST ST11, clonal complex 11 (the hypervirulent lineage associated with outbreaks). - Age peaks were in <5 years (18%; 21/115), 15–24 years (23%; 26/115), and 25–44 years (22%; 25/115); all IMD in the <5 and 15–24 groups was **MenB**. - **MenY** cases concentrated in adults ≥65 years (6/8 MenY cases), making up 33% (6/18) of IMD in that age bracket. - Antimicrobial susceptibility testing on cultured isolates (n = 76) used CLSI criteria: 8% (6/76) penicillin resistant (MIC ≥ 0.5 mg/L); 64% (49/76) intermediate (MIC 0.125–0.25 mg/L); 28% (21/76) penicillin susceptible (≤ 0.064 mg/L). - All tested isolates were susceptible to **ceftriaxone**, ciprofloxacin and rifampicin. - Data presented are surveillance-derived; the report did not provide additional clinical outcomes, treatment regimens, or molecular methods beyond finetyping and MLST declarations where noted.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43035020/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43035020/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43035020/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43035020/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43035020/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43035020/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43035020/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43035020/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43035020/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43035020/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43035020/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43035020/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43035020/#abstract) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43035020/#mesh-terms) Title & authors Abstract MeSH terms Commun Dis Intell (2018) Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Commun+Dis+Intell+%282018%29%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Commun+Dis+Intell+%282018%29%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) . 2026 Nov 16:50. doi: 10.33321/cdi.2026.50.063. # Australian Meningococcal Surveillance Programme Annual Report, 2025 [Monica Lahra](https://pubmed.ncbi.nlm.nih.gov/?term=Lahra+M&cauthor_id=43035020)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43035020/#full-view-affiliation-1 "NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au."), [Tiffany Hogan](https://pubmed.ncbi.nlm.nih.gov/?term=Hogan+T&cauthor_id=43035020)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43035020/#full-view-affiliation-2 "NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia.") Affiliations Expand ### Affiliations * 1 NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au. * 2 NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia. * PMID: **43035020** * DOI: [ 10.33321/cdi.2026.50.063 ](https://doi.org/10.33321/cdi.2026.50.063) Item in Clipboard # Australian Meningococcal Surveillance Programme Annual Report, 2025 Monica Lahra et al. Commun Dis Intell (2018). 2026. Show details Display options Display options Format Abstract PubMed PMID Commun Dis Intell (2018) Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Commun+Dis+Intell+%282018%29%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Commun+Dis+Intell+%282018%29%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) . 2026 Nov 16:50. doi: 10.33321/cdi.2026.50.063. ### Authors [Monica Lahra](https://pubmed.ncbi.nlm.nih.gov/?term=Lahra+M&cauthor_id=43035020)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43035020/#short-view-affiliation-1 "NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au."), [Tiffany Hogan](https://pubmed.ncbi.nlm.nih.gov/?term=Hogan+T&cauthor_id=43035020)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43035020/#short-view-affiliation-2 "NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia.") ### Affiliations * 1 NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au. * 2 NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia. * PMID: **43035020** * DOI: [ 10.33321/cdi.2026.50.063 ](https://doi.org/10.33321/cdi.2026.50.063) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract In Australia, both probable and laboratory-confirmed cases of invasive meningococcal disease (IMD) are reported to the National Notifiable Diseases Surveillance System (NNDSS). When compared to 2024, the number of IMD notifications in 2025 decreased by 13% to 118. IMD was confirmed by laboratory testing in 115/118 (97%) of 2025 IMD cases, with 66% (76/115) diagnosed by bacterial culture and 34% (39/115) by nucleic acid amplification testing. The genogroup was determined for 93% of laboratory-confirmed cases (107/115): genogroup B (MenB) accounted for 82.2% of infections (88/107); MenW and MenY for 7.5% of disease (8/107) each; MenC for 1.9% (2/107); and MenA for 0.9% (1/107). Finetyping was available for 67% of the cases for which the genogroup was determined (72/107). In MenB isolates, 28 porA types were detected: the most prevalent from amongst these were P1.7-2,4 (21%; 12/58) and P1.7,16-26 (14%; 8/58). Of the eight MenW isolates in 2025, six were finetyped and identified as porA type P1.5,2, MLST (ST) 11 and belonging to the clonal complex 11, the hypervirulent strain reported in outbreaks in Australia and overseas. In MenY infections, four porA types were detected from the five isolates finetyped: P1.21,16; P1.5,10-1; P1.5-1,10-1; and P1.5-2,10-1, with no dominant porA type detected. One of the two MenC isolates was typed, identifying as P1.5-2,10-1 and the single MenA isolate identified as P1.5-2,10. Peaks of IMD occurred in children aged less than 5 years, in those aged 15-24 years, and in adults aged 25-44 years, accounting for 18% (21/115), 23% (26/115) and 22% (25/115) of laboratory-confirmed cases, respectively. In children aged under 5 years, 100% of IMD (21/21) was MenB; in those aged 15-24 years, 100% of IMD (25/25) was MenB; and in those aged 25-44 years, 82% of IMD (18/22) was MenB, with three MenW cases and one MenC case reported in this age group. IMD was reported in all age groups: < 5 years (18%; 21/115); 5-9 years (5%; 6/115); 10-14 years (2.6%; 3/115); 15-24 years (23%; 26/115); 25-44 years (22%; 25/115); 45-64 years (12%; 14/115); and in those aged 65 years and older (17%; 20/115). Whilst MenB predominated in all age groups, the majority of MenY IMD cases (6/8) were reported in adults aged 65 years and older, among whom it accounted for 6/18 cases (33%). All cultured IMD isolates available for antimicrobial susceptibility testing (n = 76) were tested for ceftriaxone and penicillin. Minimum inhibitory concentration (MIC) values were reported using Clinical Laboratory Standards Institute (CLSI) interpretative criteria: 8% (6/76) were defined as penicillin resistant (MIC value ≥ 0.5mg/L); 64% (49/76) had intermediate susceptibility to penicillin (MIC values 0.125 and 0.25 mg/L); and 28% (21/76) were susceptible to penicillin (MIC values ≤ 0.064 mg/L). All isolates tested were susceptible to ceftriaxone, ciprofloxacin and rifampicin. **Keywords:** Neisseria meningitidis; antimicrobial resistance; disease surveillance; invasive meningococcal disease. © Commonwealth of Australia CC BY-NC-ND. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## MeSH terms * Adolescent Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adolescent%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adolescent) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Australia / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Australia%2Fepidemiology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Australia) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Child Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Child%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Child) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Child, Preschool Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Child%2C+Preschool%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Child%2C+Preschool) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Genotype Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Genotype%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Genotype) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Infant Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Infant%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Infant) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Meningococcal Infections* / diagnosis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Meningococcal+Infections%2Fdiagnosis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Meningococcal+Infections) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Meningococcal Infections* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Meningococcal+Infections%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Meningococcal+Infections) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Meningococcal Infections* / microbiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Meningococcal+Infections%2Fmicrobiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Meningococcal+Infections) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Middle Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Middle+Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Middle+Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Neisseria meningitidis* / classification Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neisseria+meningitidis%2Fclassification%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neisseria+meningitidis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Neisseria meningitidis* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neisseria+meningitidis%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neisseria+meningitidis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Neisseria meningitidis* / isolation & purification Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neisseria+meningitidis%2Fisolation+and+purification%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neisseria+meningitidis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Population Surveillance Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Population+Surveillance%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Population+Surveillance) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) * Young Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Young+Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Young+Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43035020/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43035020/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43035020/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43035020%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43035020/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.go
## Related Clinical Research

- [Economic value of gonorrhea resistance testing in the US: cost-neutral price thresholds](https://medichelpline.com/clinical-feed/plos-medicine-0-economic-value-of-gonorrhea-resistance-testing-in-the-united-states-a-multi.md)
- [Bacterial profile and mortality predictors in necrotizing fasciitis — multicentre Uganda study](https://medichelpline.com/clinical-feed/pubmed-43049839.md) (DOI: 10.1007/s15010-026-02767-1)
- [Economic value of gonorrhea resistance testing in the US: multi-perspective model](https://medichelpline.com/clinical-feed/pubmed-43043955.md) (DOI: 10.1371/journal.pmed.1005073)
- [Clinical and epidemiological profile of invasive non-typhoidal Salmonella disease in Ghana](https://medichelpline.com/clinical-feed/plos-one-23-clinical-and-epidemiological-characteristics-of-invasive-non-typhoidal.md)
- [Multidrug-resistant Salmonella in Fruit Bats and Shared Water Sources in Bangladesh](https://medichelpline.com/clinical-feed/plos-one-22-ecology-and-epidemiology-of-multidrug-resistance-salmonella-in-fruit-bats-and.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.